The degree of bone marrow fibrosis in chronic myelogenous leukemia is not a prognostic factor with imatinib mesylate therapy

Hagop M. Kantarjian, Carlos E. Bueso-Ramos, Moshe Talpaz, Susan O'Brien, Francis Giles, Mary Beth Rios, Jianqin Shan, Jorge Cortes

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Fingerprint Dive into the research topics of 'The degree of bone marrow fibrosis in chronic myelogenous leukemia is not a prognostic factor with imatinib mesylate therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences